Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome
Mediators of Inflammation · 2026-01 · 2026 (1)
DOI: 10.1155/mi/6617402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 23.05.2026. Verfasst von Jiao Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, 401147, China, cqmu.edu.cn. Hauptthemen laut MEDLINE: Endometriosis, Biomarkers, Proteome. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Open Research Grant from the Key Laboratory of Perinatal Medicine, Chongqing Health Commission.
Abstract (Originalsprache)
Background
There is currently no consensus on the etiology, pathogenesis, or treatment of endometriosis (EM). The discovery of disease‐associated plasma proteins with causal genetic evidence provides an opportunity to identify new EM biomarkers and therapeutic targets.
Methods
Protein quantitative trait loci (pQTLs) were derived from plasma proteomic associations in the UK Biobank Pharma Proteomics Project (UKB‐PPP). Genetic associations with EM were obtained from the FinnGen cohort. The associations between proteins and the risk of EM were estimated by cis‐Mendelian randomization (cis‐MR) and validated using the GWAS catalog dataset of EM. Colocalization, protein–protein interaction (PPI) analysis, functional enrichment analysis, transcriptome differential expression gene (DEG) analysis and druggability evaluation were further performed to explore potential biomarkers and therapeutic targets for EM.
Results
Overall, genetically predicted levels of 23 plasma proteins were associated with EM risk, with five proteins validated via replication analysis (ALPI, KHK, HSPG2, STXBP1, and POLR2F). Lower levels of genetically predicted ALPI (odds ratio [OR]: 0.89, 95% confidence interval [CI] 0.83–0.95), HSPG2 (OR: 0.81, 95% CI 0.75–0.88), POLR2F (OR: 0.51, 95% CI 0.36–0.73), and STXBP1 (OR: 0.75, 95% CI 0.64–0.86) were associated with an increased risk of EM. Elevated levels of KHK (OR: 1.09, 95% CI 1.05–1.13) were associated with an increased risk of EM. We also identified ALPI, KHK, HSPG2, STXBP1, and POLR2F as potential drug targets and biomarkers for EM.
Conclusion
A series of comprehensive analyses emphasized the potential role of ALPI, KHK, HSPG2, STXBP1, and POLR2F in EM and suggested that these genes could be developed into exact biomarkers and therapeutic targets for this condition in future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, 401147, China, cqmu.edu.cn.
- Department of Epidemiology, Joint International Research Laboratory of Reproduction and Development of the Ministry of Education of China, School of Public Health, Chongqing Medical University, Chongqing, 400016, China,…
- Department of Pharmacology, Academician Workstation, Changsha Medical University, Changsha, 410219, China, csmu.edu.cn.
ORCID-Profile: Jiao Zheng, Ying-Ling Yao, Xin-Zhen Chen, Li-Juan Fu, Yu-Gang Chi, Zhao-Hui Zhong, Yu-Bin Ding
Förderung
- National Key Research and Development Program of China
- Open Research Grant from the Key Laboratory of Perinatal Medicine, Chongqing Health Commission
Zitieren
APA
Zheng, J., Yao, Y. L., Chen, X. Z., Fu, L. J., Chi, Y. G., Zhong, Z. H., & Ding, Y. B. (2026). Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/6617402
Vancouver
Zheng J, Yao YL, Chen XZ, Fu LJ, Chi YG, Zhong ZH, et al. Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/6617402
BibTeX
@article{Zheng2026,
author = {Zheng, Jiao and Yao, Ying-Ling and Chen, Xin-Zhen and Fu, Li-Juan and Chi, Yu-Gang and Zhong, Zhao-Hui and Ding, Yu-Bin},
title = {Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome},
journal = {Mediators of Inflammation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/mi/6617402}
}
EUVIMED